Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate-loaded Drug Vesicles for Meningeal Metastasis of Lung Cancer
NCT07559097Phase 2Recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in leptomeningeal metastasis (LM), sponsored by Henan Cancer Hospital. Started Sep 2025; status: recruiting.
02
Drugs
methotrexate
03
Conditions
leptomeningeal metastasis (LM)
Beyond the preview
Go deeper on NCT07559097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07559097.